Skip to content
Twitter
Gary K

Gary K

  • ABOUT
  • MONEY MANAGEMENT
  • COMMENTARYExpand
    • RADIO
    • TELEVISION
    • NEWSLETTER
  • CONTACT
  • LISTEN NOW
Gary K
Gary K
Latest Posts

Mylan Agrees to $465M EpiPen Classifican Settlement, Lowers Full-Year EPS Outlook @FoxBusiness

ByGary Kaltbaum October 10, 2016October 9, 2016

http://www.foxbusiness.com/markets/2016/10/07/mylan-agrees-to-465m-epipen-classifican-settlement-lowers-full-year-eps-outlook.html

Post navigation

Previous Previous
Risks in China’s banking system controllable even as bad loans rise: PBOC Zhou
NextContinue
What’s Causing the Job Growth Slowdown? @FoxBusiness

Pages

  • About Gary Kaltbaum
  • About The Show
  • Money Management
  • Consulting
  • GaryK’s Consulting Service
  • Educational Lesson GaryK Guide To Insider Buying
  • Educational Lesson: Understanding Big Stock Market Gaps
  • Gary K. Newsletter
  • Contact

Categories

  • Latest Posts
  • Radio
  • Television
  • Newsletter

Gary Kaltbaum owns Kaltbaum Capital Management, LLC (“KCM”), a state registered investment adviser. The opinions expressed herein are those of Mr. Kaltbaum and may not reflect those of KCM. The information offered in this publication is general information that does not take into account the individual circumstances, financial situation or individual needs of an investor. The information herein has been obtained from sources believed to be reliable, but we cannot assure its accuracy or completeness. Neither the information nor any opinion expressed constitutes a solicitation for the purchase or sale of any security. Any reference to past performance is not to be implied or construed as a guarantee of future results.

Charts & Data Courtesy MarketSurge. Click Here To Join MarketSurge.

  • ABOUT
  • MONEY MANAGEMENT
  • COMMENTARY
    • RADIO
    • TELEVISION
    • NEWSLETTER
  • CONTACT
  • LISTEN NOW